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Abstract
Fluorescent protein (FP) insertions have often been used to localize primary structure elements in mid-resolution 3D cryo
electron microscopic (EM) maps of large protein complexes. However, little is known as to the precise spatial relationship
between the location of the fused FP and its insertion site within a larger protein. To gain insights into these structural
considerations, Fo ¨rster resonance energy transfer (FRET) measurements were used to localize green fluorescent protein
(GFP) insertions within the ryanodine receptor type 1 (RyR1), a large intracellular Ca
2+ release channel that plays a key role in
skeletal muscle excitation contraction coupling. A series of full-length His-tagged GFP-RyR1 fusion constructs were created,
expressed in human embryonic kidney (HEK)-293T cells and then complexed with Cy3NTA, a His-tag specific FRET acceptor.
FRET efficiency values measured from each GFP donor to Cy3NTA bound to each His tag acceptor site were converted into
intermolecular distances and the positions of each inserted GFP were then triangulated relative to a previously published X-
ray crystal structure of a 559 amino acid RyR1 fragment. We observed that the chromophoric centers of fluorescent proteins
inserted into RyR1 can be located as far as 45 A ˚ from their insertion sites and that the fused proteins can also be located in
internal cavities within RyR1. These findings should prove useful in interpreting structural results obtained in cryo EM maps
using fusions of small fluorescent proteins. More accurate point-to-point distance information may be obtained using
complementary orthogonal labeling systems that rely on fluorescent probes that bind directly to amino acid side chains.
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Introduction
In structural studies of proteins using cryo electron microscopy,
fusions of fluorescent proteins have been used to localize primary
structure elements to cryo EM maps of large protein complexes. In
these structural maps, the small fusion protein appears as a ‘‘bulge’’
of density within the larger protein, which is often interpreted as
the location of the fusion site. This method has been used to
localize specific domains in protein complexes such as viral capsids
or heteromultimeric GTPases [1,2,3,4]. This innovative technique
has been used extensively in sequence localizations within the
cardiac ryanodine receptor isoform (RyR2), a large (subunit
Mr,560 kDa) homotetrameric intracellular Ca
2+ channel com-
plex that plays an intrinsic role in cardiac muscle excitation
contraction coupling. Many RyR2 primary sequence elements
have been localized to the ‘‘clamp domains’’, structures located in
the corners of the RyR homotetramer. These sequence elements
include positions 1366 [5] and 1874 [6], which are located in
regions of high sequence divergence between the three RyR
isoforms. Other positions localized to the clamp region using this
technique include positions 437 [7] and 2367 [8], located within
clusters of mutation sites that can lead to cardiac muscle disease.
Finally, both the N-terminus of the type 3 RyR [9] and
a regulatory phosphorylation site at position 2808 of RyR2 [10]
have been localized to the clamp region.
While small protein fusions combined with cryo EM microscopy
haveyieldedimportantstructuralinformationaboutRyR2,someof
thesefindingsareatvariancewitharecent study[11]thatdescribed
the atomic structure of a 559 amino acid N-terminal fragment from
RyR1, the skeletal muscle RyR isoform. The size and shape of this
fragment was sufficient to enable its precise docking to a structure
that surrounds a hollow vestibule within the cytoplasmic ‘‘foot’’
portion of RyR1 [11]. However, previous cryo EM studies using
either docking of N-terminal crystal structures [12,13] from the
structurally similar inositol trisphosphate receptor [14] or localiza-
tion of protein fusions at the N-terminus of RyR3 [9] or after amino
acid position 437 of RyR2 [7] suggested that this RyR N-terminal
domain was located in the clamp domains which are ,100 A ˚ from
thelocationdeterminedbydockingtheRyR1crystalstructure[10].
Thereasonforthesedivergentlocalizationsisnotknownalthoughit
has been suggested [10] that the size of the inserted protein
combined with the length of the glycine-rich linkers used to tether
the protein to the RyR in the cryo EM studies may contribute to
a significant difference in the position of inserted protein relative to
its insertion point in the RyR.
To understand the spatial relationship between the location of
the center of mass of the fused FPs and their insertion sites within
RyR1, we utilized a cell-based FRET method to probe the
structure of GFP-RyR1 fusion proteins. This method relies on
a Cy3/bis-nitrilotriacetic acid (NTA)/Ni
2+ conjugate (termed
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38594Cy3NTA) that can be targeted specifically to poly-histidine ‘‘tags’’
engineered into RyR1. Cy3NTA can then undergo energy transfer
with green fluorescent protein (GFP) fused into the primary
structure of RyR1 (Fig. 1A). The FRET efficiency provides an
indication of the relative proximity of these two fluorophores
within RyR1.
FRET from GFP fused at each of 3 positions within the N-
terminal 620 amino acids of RyR1 was measured to each of 6
different His10 tags placed throughout the primary sequence of
this region. These FRET results were then used to triangulate
each of the fused GFPs relative to the X-ray crystal structure of
the N-terminal RyR1 fragment [11]. Finally, the resulting model
of the N-terminal crystal structure and triangulated GFPs was
docked to a cryo EM map of RyR1 [15] and the results
compared with previous localizations of fused fluorescent proteins
within the RyR using cryo EM techniques [9,16].
Results
Experimental Approach
GFP and His10 tags were introduced into each of three
structural sub-domains predicted by X-ray crystallography
[11,17,18] (Fig. 1B). Thus, a set of constructs was created with
GFP fused to position 1 of RyR1, a modification which affects
neither orthograde nor retrograde signaling with the CaV1.1
channel during EC coupling [9,19]. A second set of constructs
contained GFP fused in the middle structural subdomain at
position 291. Finally, a third set of constructs was created with
GFP fused at position 620, which is located beyond the crystallized
area but lies at the C-terminal end of a contiguous series of alpha
helices predicted by secondary structure analysis [20,21]. FRET
acceptor binding sites were engineered by inserting His10 tags
either at positions 2, 76, 181, 290, 519 or 619. Constructs were
named according to the positions of the GFP and His10 tag
insertion sites. For example, construct GFP
291His
519 contained
GFP and a His10 tag inserted after residues 291 and 519 of
wtRyR1, respectively.
Functional Testing of His-tagged GFP-RyR1 Fusion
Constructs
All His-tagged GFP-RyR1 fusion proteins exhibited character-
istic GFP fluorescence when expressed in HEK-293T cells (data
not shown) and all constructs were expressed as full-length
proteins, as confirmed using Western blot analysis (Fig. S1). In
addition, all constructs released Ca
2+ in response to the RyR1
agonist, caffeine (Fig. 2). Constructs containing GFP at positions 1,
291 or 620 but lacking a His10 tag (Fig. 2A) had similar EC50
values for caffeine activation (1.03, 1.15 and 1.57 mM respective-
ly) (Fig. 2B–D) compared to wtRyR1 expressed in HEK-293T
cells (EC50=1.43 mM). All GFP-RyR1 fusion proteins containing
His10 tags were also functional and the majority of these constructs
had EC50 values similar to wtRyR1 (Fig. 2B–D). Only
GFP
1His
290, GFP
291His
619, GFP
620His
2, and GFP
620His
290 had
significantly higher EC50 values compared to wtRyR1 although
these changes were modest (less than 4-fold) (Table 1). Untrans-
Figure 1. FRET-based method and GFP/His10 tag insertion sites used for structural analysis of RyR1. (A) Cy3NTA site-specifically binds to
a His10 tag inserted within the primary structure of RyR1 (black bar; top) resulting in FRET from a nearby fused GFP fluorescent donor (bottom). The
FRET efficiency is indicative of the proximity of the donor and acceptor fluorophores within RyR1. (B) Primary structure of RyR1 (black bar) and the N-
terminal functional domain (gray bar) are indicated. Positions of GFP and His10 tag insertions, malignant hyperthermia mutation sites (diamonds), as
well as the location of the beta sheet (arrows) and alpha helical (diamond-flanked line) subdomains [11,21] are shown.
doi:10.1371/journal.pone.0038594.g001
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2+ in response to caffeine
(data not shown).
A column-binding assay [22] was used to verify surface
exposure of the inserted His10 tags (Fig. S2). Constructs with
GFP at position 1 and His10 tags at either the N-terminus or at
positions 76, 181, 290 or 519 all bound to an NTA-agarose
column whereas constructs lacking a His10 tag did not. This
finding indicates that these inserted His10 tags were accessible to
Ni
2+/NTA-agarose and thus should bind the FRET acceptor,
Cy3NTA, which interacts with His10 tags via the same mechanism
[23].
FRET Measurements
EnergytransfermeasurementswereperformedonallGFP-RyR1
fusion proteins expressed in HEK-293T cells (Fig. 3, Table 2). No
energy transfer was detected within constructs lacking a His10 tag
(Fig.3A–C).Incontrast,thehighestFRETefficiencylevelsobserved
in this study were between GFP donors and Cy3NTA acceptors
targeted to His10 tags placed adjacent to the GFP insertion sites
(E=0.66, 0.57, and 0.54 for GFP
1His
N-term, GFP
291His
290 and
GFP
620His
619, respectively, Fig. 3A–C).
For constructs with GFP fused at position 1 (Fig. 3A), equal
FRET efficiencies (E=0.23) were measured when Cy3NTA was
targeted to His10 tags at positions 76 and 181. The FRET
efficiency from GFP at position 1 to Cy3NTA bound to position
290 was slightly lower (E=0.17) and the FRET efficiency
decreased further when Cy3NTA was targeted to positions 519
and 619 (E=0.14 and 0.08, respectively).
FRET efficiency measured from GFP at position 291 was
highest to Cy3NTA targeted to a His10 tag at position 2 (E=0.34)
whereas energy transfer efficiencies from GFP
291 to Cy3NTA
bound to His10 tags at positions 76, 181, 519 and 619 were more
uniform with values of 0.16, 0.25, 0.19 and 0.24 respectively
(Fig. 3B).
FRET efficiencies measured from GFP at position 620 (Fig. 3C)
were highest to Cy3NTA bound to His10 tags at positions 291 and
Figure 2. Functional analysis of His-tagged GFP-RyR1 fusion constructs. (A) Caffeine-induced Ca
2+ transients were measured using Fluo-4-
based intracellular Ca
2+ imaging for HEK-293T cells expressing the indicated GFP-RyR1 fusion constructs. A graded series of caffeine concentrations
were perfused as indicated (black bars). Individual representative traces indicate changes in Fluo-4 fluorescence normalized to resting fluorescence
(F/F0). Calibration bar=0.5 F/F0 ratio units vs. 50 sec. (B-D) Normalized caffeine dose response curves for His-tagged constructs containing GFP fused
to position 1 (B), position 291 (C) or position 620 (D) of RyR1. Individual data points represent mean +/2 S.E.M.
doi:10.1371/journal.pone.0038594.g002
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Cy3NTA targeted to His10 tags at positions 76 and 181 were
roughly equivalent (E=0.18 and 0.21 respectively) whereas the
measured FRET efficiency was lowest to Cy3NTA bound to
a His10 tag at position 2 (E=0.11).
Calibration of FRET Measurements
To correlate these FRET measurements with donor/acceptor
distances, a second FRET acceptor comprised of Cy5 coupled to
2 NTA/Ni
2+ groups (Cy5NTA; Fig. 4A) was used. The absor-
bance spectrum of Cy5NTA exhibited a smaller overlap with the
emission spectrum of GFP, relative to Cy3NTA (Fig. 4B) resulting
in a shorter Fo ¨rster distance (R0) of 42.9 A ˚ compared to Cy3NTA
(62.5 A ˚). In vitro FRET measurements (Fig. S3) revealed that both
compounds could bind to His10-tagged GFP (GFPHis10), resulting
in quenching of GFP fluorescence via FRET. However, Cy5NTA
was a less efficient FRET acceptor with GFP (E =0.54) compared
to Cy3NTA (E=0.88) (Fig. 4C), a finding consistent with the
relative R0 values of the two FRET pairs.
These energy transfer efficiencies corresponded to donor-
acceptor distances of 44.6 A ˚ and 41.8 A ˚ for the GFP/Cy3NTA
and GFP/Cy5NTA FRET pairs, respectively (Fig. 4D). These
distances diverged when higher order binding stoichiometries were
Table 1. Summary of EC50 Values for Caffeine Activation of
His-tagged GFP-RyR1 Fusion Constructs.
Construct EC50 (mM)
a 95% C.I. (mM)
b N
c
wtRyR1 1.43 1.26–1.62 94
GFP
1 Series
GFP
1(-His) 1.03 0.55–1.91 13
GFP
1His
N-term 1.71 1.29–2.26 23
GFP
1His
76 1.37 0.93–2.02 7
GFP
1His
181 1.23 0.68–2.22 6
GFP
1His
290 5.01
d 4.03–6.24 18
GFP
1His
519 1.35 0.89–2.04 21
GFP
1His
619 1.95 1.60–2.38 17
GFP
291 Series
GFP
291(-His) 1.15 0.68–2.14 12
GFP
291His
2 1.10 0.59–2.05 14
GFP
291His
76 1.59 1.08–2.32 11
GFP
291His
181 1.27 0.90–1.81 13
GFP
291His
290 1.41 0.87–2.28 20
GFP
291His
519 0.93 0.71–1.22 22
GFP
291His
619 4.02
d 2.86–5.67 11
GFP
620 Series
GFP
620(-His) 1.57 1.05–2.36 20
GFP
620His
2 3.20
d 2.38–4.21 29
GFP
620His
76 1.23 0.89–1.69 19
GFP
620His
181 1.05 0.76–1.46 16
GFP
620His
290 3.21
d 2.24–4.58 12
GFP
620His
519 3.06 1.86–5.04 6
GFP
620His
619 2.07 1.10–3.87 14
aMean EC50 values for caffeine activation of the indicated constructs.
b95% confidence interval of the mean EC50 value.
cNumber of measurements.
dEC50 value significantly changed relative to wtRyR1 (p,0.05).
doi:10.1371/journal.pone.0038594.t001
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strating 1:1 binding of NTA-based fluorophores to poly-histidine
tags [23,24,25]. The average of these distances (43.2 A ˚) was
18.2 A ˚ longer than the predicted distance from the chromophoric
center of GFP to its N-terminus, as derived from X-ray
crystallographic data [26]. We attributed this difference to the
physical dimensions of the His10 tag itself as well as the Cy3NTA
donor, both of which most likely obscure the location of the His10
tag insertion point at the N-terminus of GFP. However, the use of
this second FRET acceptor demonstrated that these FRET
measurements reflect the distance between the donor and acceptor
fluorophores while also providing an indication of the accuracy of
these measurements.
Triangulation of GFP Insertions
To compare these FRET results in the context of the atomic
structure of a 559 amino acid fragment from the RyR1 N-
terminal domain [11], the physical locations of GFP inserted at
positions 1, 291 and 620 were triangulated (see Methods) (Fig. 5).
The N-terminally fused GFP was triangulated from distances
measured from the His10 tag insertion sites at the N-terminus as
well as positions 76, 181, and 290. Distances derived from FRET
measurements involving position 519 did not converge with
triangulations based on FRET measurements to the other
positions and thus were not considered in the localization of
the N-terminal GFP (nor the other GFP fusions) (see Discussion).
The C-terminus of the triangulated GFP appeared to be
approximately 19 A ˚ from the alpha carbon of glutamine 12,
the first residue within the crystal structure of the N-terminal
RyR1 domain. The distance from the alpha carbon of glutamine
12 to the furthest end of the GFP barrel was approximately
58 A ˚.
GFP insertions at position 291 and 620 were also triangulated
from distances to the N-terminus of RyR1 as well as positions 76,
181 and 290 (Fig. 5). The N- and C-terminal attachment points of
GFP inserted at position 291 appeared to be ,25 A ˚ from its
insertion point. GFP at position 620 could also be triangulated
despite the fact that its insertion site in RyR1 lies outside the
crystallized area of this domain.
Placement of GFP Insertions within the Cryo EM Structure
of RyR1
The complex consisting of the crystal structure of the N-
terminal RyR1 fragment and the triangulated GFPs was docked
to the cryo EM structure of RyR1 at a cytoplasmic ‘‘vestibule’’
proximal to the 4-fold symmetry axis of the channel (Fig. 6A,B).
After docking, FRET from donor/acceptor sites between all
subunits was considered and the position of the inserted GFPs
adjusted as required in order to provide triangulation coordinates
of these insertions that best matched our experimental FRET
data (see Methods). The comparison of FRET levels determined
experimentally and predicted FRET based on the location of the
GFPs docked to the 3D structure of RyR1 is indicated in Table 2.
GFP fused at the N-terminus projected into a central cavity
within RyR1 that is part of the ‘‘vestibule’’ formed by the 4 N-
terminal domains (Fig. 6C,D). The chromophoric center of this
GFP was 101 A ˚ from the position of glutathione-S-transferase
(GST) fused to the N-terminus of RyR3 (red dot) as determined
using cryo EM microscopy [7]. However, a secondary difference
density reported in that study (Fig. 6, orange dot) is as close as
25 A ˚ to our localization of the N-terminally fused GFP. Thus, the
cryo EM based localization of N-terminally fused GST to this
secondary difference density is more consistent with our results
and most likely represents the true location of GST fused to this
position.
GFPs fused at positions 291 and 620 projected above the surface
of the protein (Fig. 6B). The chromophoric center of GFP at
position 620 at this location was 93 A ˚ from a FRET-based
localization of cyan fluorescent protein (CFP) fused at position 626
(Fig. 6, cyan dot) [16]. However, an alternative localization of GFP
fused at position 620 (GFP620 alt, Fig. 6) could also be identified
that projected into an interior location only 38 A ˚ from the
published localization of CFP fused at position 626 in RyR2 [16].
Thus, this alternative localization of GFP fused at this position is
more consistent with this previous study.
Figure 3. FRET analysis of His-tagged GFP-RyR1 fusion
constructs. (A–C) FRET efficiencies measured from His-tagged
constructs containing GFP fused to position 1 (A), position 291 (B) or
position 620 (C) of RyR1 expressed in HEK-293T cells. Data points
represent mean FRET efficiency +/2 SEM for the indicated constructs
determined from recovery of donor fluorescence after acceptor
photobleaching as described in Methods.
doi:10.1371/journal.pone.0038594.g003
Table 2. Summary of FRET efficiency values for His-tagged
GFP-RyR1 fusion constructs.
Construct N
a FRET (Observed)
b FRET (Predicted)
c
GFP
1 Series
GFP
1(-His) 149 20.02 N/A
GFP
1His
N-term 93 0.66 0.59
GFP
1His
76 80 0.23 0.62
GFP
1His
181 52 0.23 0.25
GFP
1His
290 91 0.17 0.27
GFP
1His
519 106 0.14 0.16
GFP
1His
619 64 0.08 N/A
GFP
291 Series
GFP
291(-His) 45 20.01 N/A
GFP
291His
2 40 0.34 0.31
GFP
291His
76 20 0.16 0.11
GFP
291His
181 61 0.25 0.32
GFP
291His
290 42 0.57 0.62
GFP
291His
519 57 0.19 0.19
GFP
291His
619 82 0.24 N/A
GFP
620 Series
GFP
620(-His) 133 0.00 GFP
620 GFP
620 alt
GFP
620His
2 26 0.11 0.11 0.16
GFP
620His
76 75 0.18 0.28 0.20
GFP
620His
181 51 0.21 0.21 0.24
GFP
620His
290 81 0.33 0.33 0.30
GFP
620His
519 42 0.29 0.29 0.81
GFP
620His
619 53 0.54 N/A
aNumber of measurements.
bMean energy transfer values observed in the FRET experiments.
cFRET efficiency values predicted after docking the model comprised of the
atomic structure of the N-terminal domain and triangulated GFPs to the
cytoplasmic vestibule location in the cryo EM structure of RyR1 as indicated in
Figure 6. The 2 sets of values for the GFP620 series of constructs represent
predicted FRET to GFP620 placed at either of the two indicated positions shown
in Figure 6.
doi:10.1371/journal.pone.0038594.t002
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FRET-Based Method
The Cy3NTA labeling system employed in this study enabled
the targeting of small fluorophores to specific locations within
RyR1 via insertion of His10 tags to these locations. Non-specific
binding sites for NTA-based fluorophores on RyR1 appeared to
be absent since FRET was not observed for GFP-RyR1 fusion
constructs lacking a His10 tag and also because these constructs did
not bind to an NTA-agarose column. In contrast, all His10-tagged
positions within RyR1 could bind to the NTA-agarose column,
indicating that they were all surface-exposed. In addition, FRET
could be measured to all His10-tagged sites, thus confirming the
ability of Cy3NTA to bind to each of them. While differences in
Cy3NTA binding affinity to the different sites may contribute to
differences in FRET, this seems unlikely since the His10 tag
binding sites are predicted to be exposed on the surface of the
atomic structure of the RyR fragment and because Cy3NTA
binding affinity to His10 tags either in vitro or in cells are consistent
with each other (Kd,100 nM) ([22] and Fig. S4) Finally, through
the use of a second NTA-based fluorophore, Cy5NTA, we
confirmed that these FRET acceptors bind to His10 tags with 1:1
stoichiometry, thus indicating that differing measured FRET
efficiencies do not arise from differing Cy3NTA:His10 tag binding
stoichiometries.
The measured FRET efficiencies were indicative of molecular
distances between the donor and acceptor fluorophores targeted to
RyR1. The highest FRET efficiency measured in this study was
for the GFP
1His
N-term RyR1 construct, where a short 5 amino acid
spacer element separated the His10 tag and GFP. Constructs with
a 12 amino acid glycine rich linker separating the donor- and
acceptor-binding site (GFP
291His
290 and GFP
620His
619) had
slightly lower FRET efficiency levels that were consistent with
the relatively longer linker between donor and acceptor fluor-
ophores. In addition, FRET measurements of His10-tagged GFP
using Cy3NTA or Cy5NTA yielded donor-acceptor distances that
were consistent with each other as well as the molecular
dimensions of GFP.
Triangulation of GFP Insertions
GFP fused to each of the three positions in RyR1 could be
localized to a unique position in space based on FRET efficiencies
measured from 4 out of the 5 donor/acceptor pair combinations.
The inability of all 5 donor/acceptor pairs to converge on
a particular location can potentially be attributed to several
factors. First, the underlying crystal structure upon which these
triangulations were based may adopt a slightly different confor-
mation or structure within the full-length protein. This could result
from structural changes related either to the activation state of the
channel, RyR-associated proteins or differences in the relative
orientation of the three subdomains when they form native
contacts with other parts of RyR1. Second, the insertions
themselves may cause local structural perturbations. While all
GFP-RyR1 fusion proteins in this study released Ca
2+ in response
to caffeine and fusion of small proteins at other positions do not
appear to affect RyR function (for examples, see [7,8,16,27]), the
possibility remains that our modifications to the primary structure
of the RyR disrupt its tertiary structure. Finally, the inability of
GFP triangulations to converge on all 5 donor-acceptor distances
could be due to intersubunit FRET, which is dependent on the
location of these sites within the RyR homotetramer. This factor
was taken into account for the docking experiments and is
discussed below.
Figure 4. Calibration of FRET measurements using Cy5NTA. (A) Predicted structures of Cy3NTA and Cy5NTA. The number of methine groups
in each compound is indicated (n). (B) Normalized GFP emission spectrum (green, lex=476 nm), as well as Cy3NTA (red) and Cy5NTA (blue)
absorbance spectra. Shaded regions indicate areas of spectral overlap. (C) FRET efficiencies measured within GFPHis10 using either 2 mM Cy3NTA (red)
or 2 mM Cy5NTA (blue) as a FRET acceptor. Values represent mean +/2 S.E.M. (D) Donor-acceptor distances within GFPHis10 determined from
theoretical FRET curves derived from the R0 for either GFP/Cy3NTA (R0=62.5 A ˚; red curve) or GFPCy5NTA (R0=42.9 A ˚; blue). Black lines indicate
observed FRET values from panel (C) and corresponding donor/acceptor distances for each FRET pair.
doi:10.1371/journal.pone.0038594.g004
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GFPs was triangulated relative to the crystal structure of the RyR1
domain (Fig. 5). The chromophoric centers of the triangulated
GFPs were located ,40 A ˚ from their insertion points (when
known). Given the 45-A ˚ length of GFP, portions of the inserted
protein could be as close as 19 A ˚ and as far as 63 A ˚ from the
insertion point. These uncertainties in the position of the fusion
protein inserted within the RyR may have contributed to the
discrepancies in the localization of the N-terminus of the RyR to
the cryo EM structure of the protein [9,11,14]. The results from
the present study provide a more precise estimation of these
uncertainties, which can be used to interpret cryo EM and FRET-
based structural determinations of the RyR that rely on these types
of protein insertions.
Docking Experiments
We docked the RyR crystal structure to the central vestibule
location located near the 4-fold symmetry axis of the protein [11].
After docking the complex to this location, we accounted for
potential FRET between subunits by adjusting the triangulation of
GFPs at each position to yield theoretical FRET values consistent
with our observed FRET measurements. This adjustment was to
be expected because these central cytoplasmic locations are
adjacent to each other in the 3D structure of RyR1 and thus,
inter-subunit energy transfer is possible. After adjustment of the
position of these FPs, we observed several different types of
localizations of these inserted GFPs within the 3D map of RyR1.
FPs were located either within internal cavities of RyR1 (GFP at
position 1), on the surface of the protein (GFP291) or in regions of
high electron density (GFP620). Thus, different types of structural
insertions can potentially occur when using fluorescent proteins for
either cryo EM or FRET-based studies, and these factors should
be kept in mind when interpreting data from these types of
experiments. However, our ability to triangulate and localize GFP
fusions at positions 1 and 620 to positions previously determined
by other groups [9,16] reconciles the seemingly conflicting docking
of the atomic structure of the N-terminal domain and previous
cryo EM-based localizations of primary sequence elements in this
region. A recent cryo EM-based study also maps GFP fused at
RyR2 residue 310 to this central vestibule location [28].
Perspective
The use of fluorescent protein fusions in either FRET-based or
cryo EM-based determinations of protein structure clearly has both
Figure 5. Triangulation of GFP insertions relative to the crystal structure of an N-terminal RyR1 fragment. (A) Overall view of the
complex indicating the locations of the inserted GFPs and His10 tags. The two individual beta sheet subdomains are indicated in cyan (amino residues
12–204) and dark blue (residues 205–394), respectively. The alpha helical subdomain (residues 395–532) is indicated in red. His10 tag insertion sites
are colored white on the ribbon depiction of the crystal structure. The X-ray crystal structure of GFP [26] inserted at each site is indicated in green. (B)
The complex rotated 45u relative to the view in (A) along the indicated axis is shown. Scale bars, 20 A ˚.
doi:10.1371/journal.pone.0038594.g005
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a fluorescent protein to a specific location within a large protein
complex with essentially 100% labeling efficiency is a clear
advantage. In addition, most of the FP fusions identified in cryo
EMstudiesappeartobelocalizedatthesurfaceoftheprotein.These
insertions most likely cause less structural disturbance relative to
insertions in internal portions of the channel, which could
complicate analysis of structural results obtained with either
fluorescent proteins or small organic dyes. However, the disadvan-
tage of using fluorescent protein fusions is the significant distance
betweenthefusedproteinanditsinsertionsitewithinalargerprotein
complex,whichaddsalayerofuncertaintywheninterpretingeither
cryo EM or FRET data. Clearly, orthogonal labeling systems are
requiredthatrelyonsmallerproteintagsthatcanthenactasbinding
sites for fluorescent probes and these systems are currently being
developed and implemented in our laboratory.
Materials and Methods
Ethics Statement
This study used the human embryonic kidney cell line (HEK-
293T) obtained from the American Type Culture Collection
(ATCC). The use of these cells was approved by the Partners
Institutional Biosafety Committee.
Figure 6. Docking of RyR1 N-terminal crystal structure and triangulated GFPs to the RyR1 cryo EM map. (A) Cryo EM structure of RyR1
(gray) viewed from the ‘‘top’’ (i.e. the cytoplasmic side that would face the T-tubule membrane in situ). Crystal structure of an N-terminal RyR1
fragment [11] is docked to a central location that forms a cytoplasmic vestibule located beneath the area indicated by the dotted circle. The positions
of the GFPs (in green) inserted at the indicated positions relative to the crystal structure of the N-terminal domain docked to this position are
indicated. Colored dots depict previously published localization sites of GST fused to the N-terminus of RyR3 (orange and red; [9]), as well as CFP
fused to position 626 of RyR2 (cyan; [16]). (B) Side view of the cryo EM structure of RyR1 rotated 90u relative to panel A as indicated. (C) Oblique view
of the cryo EM structure of RyR1 with the docking to the cytoplasmic vestibule location. (D) Magnified view of this docking from the dotted box in (C).
GFP620 and GFP620alt refer to two potential localizations of GFP fused to position 620 discussed in the text. GFP at position 291 is removed to more
clearly depict the locations of the X-ray crystal structure of the N-terminal RyR1 fragment as well as the other GFP fusions.
doi:10.1371/journal.pone.0038594.g006
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GFP from Aequorea coerulescens (Takara BIO, Mountain View,CA)
was inserted at either positions 1,291 or620 of the full length rabbit
RyR1 cDNA in the pCi mammalian expression vector (Promega,
Madison,WI).TopromotefreerotationofGFP,glycine-richlinkers
similar to those used in cryo EM studies using FP insertions (for
example see [5]) were added. The protein sequence of these linkers
(in italics) at each insertion point within the wtRyR1 sequence
(underlined) are as follows: GFP at position 1 (GFP
1); GFP-
GGGGSGGGGPAGLDIMGD-RyR1, GFP
291; RyR1-
GRYLGGGGSGGGG-GFP-GGGGSGGGGRYLALTED-RyR1,
GFP
620; RyR1-NQDLGGGGSGGGG-GFP-GGGGSGGGGDLI-
TEN-RyR1.
DNA segments encoding His10 tags were inserted into the RyR1
cDNA resulting in the following protein sequences at the insertion
points: His
2; MG(H)10GYRDGGE-RyR1, His
76; RyR1-
SVR(H)10GYRALQE-RyR1, His
181; RyR1-ERYL(H)10GYL-
STA-RyR1, His
290; RyR1-TGRY(H)10GYRYLALT-RyR1,
His
519; RyR1-KEIV(H)10GYLNLLY-RyR1, His
619; RyR1-
SNQD(H)10GYQDLITE-RyR1.
Constructs with His10 tags adjacent to the inserted GFP had the
following sequences at the His tag insertion points: GFP
1His
N-term;
MGSS(H)10GSQRP-GFP-GGGGSGGGGPAGLDIMGD-RyR1,
GFP
291His
290; GRY(H)10GYRGGGGSGGGG-GFP-
GGGGSGGGGRYLALTED-RyR1, GFP
620His
619;
NQDL(H)10GYRGGGGSGGGG-GFP-GGGGSGGGGDLITEN-
RyR1.
All insertions were performed using PCR-based primer
extension followed by confirmation of correct clones using DNA
sequencing and restriction digest analysis.
Cell Culture and Ca
2+ Imaging
HEK-293T cells were propagated and then transfected with
cDNAs using polyethylenimine as described previously [22].
Three days after transfection, changes in intracellular Ca
2+ in
response to the RyR agonist caffeine were measured at 406
magnification using 2 mM Fluo-4 as a Ca
2+ indicator as described
previously [29]. Ca
2+ transient areas calculated using Microsoft
Excel were plotted as a function of caffeine concentration and then
fitted to a sigmoidal dose-response function (variable slope) to
determine EC50 values for each individual cell. These values were
then compared using a 1-way analysis of variance followed by
a Dunnett’s post-test with Prism 4.0 software (Graphpad Inc., San
Diego, CA). A significant difference in EC50 values was inferred
from a p,0.05.
Western Blot Analysis
HEK-293T cell pellets expressing each His-tagged GFP-RyR1
fusion construct were lysed for 10 min at 37 C in 150 mM
NaCl, 50 mM HEPES (pH 7.4), 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate (SDS), 1 U/ml benzonase, and
protease inhibitors (1.04 mM AEBSF, 0.8 mM aprotinin, 40 mM
bestatin, 14 mME 264, 20 mM leupeptin, 15 mM pepstatin A).
Upon addition of an equal volume of 26 sample buffer
consisting of 0.5 M Tris-HCl (pH 6.8), 4.4% SDS, 20% glycerol
and 2% 2-mercaptoethanol, samples were incubated at 37 C for
5 min and then between 50–100 mg of total protein for each
construct were loaded onto a 6% SDS-polyacrylamide gel and
the samples were electrophoresed for 2 hr at 100 V. Proteins
were then transferred to polyvinylidene difluoride membranes at
100 V for 1 hr at 4C [30]. Membranes were blocked in
blocking buffer, consisting of 5% nonfat milk in TBS-T (50 mM
Tris-HCl (pH 7.4), 150 mM NaCl and 0.05% Tween-20) for
1 hr at 4C. Membranes were then incubated in 34C anti-RyR
monoclonal antibody (Developmental Studies Hybridoma Bank,
Iowa City, IA) diluted 1:200 in blocking buffer for 1 hr at 4C
followed by extensive washing and then incubation in horse
radish peroxidase-conjugated goat anti-mouse secondary anti-
body (Sigma, St. Louis, MO) diluted 1:2000 in blocking buffer
for 1 hr at 4C. After extensive washing with TBS-T,
membranes were developed for 5 min in SuperSignal West
Dura Extended Duration chemiluminescent substrate (Thermo,
Rockford, Il) followed by a 10 min exposure on a Kodak Image
Station 4000 m PRO to detect the chemiluminescent signal.
NTA-agarose Column Chromatography
Surface exposure of His10 tags inserted into GFP-RyR1 fusion
proteins was determined via fractionation of whole cell lysates
from HEK-293T cells expressing each indicated construct on an
NTA-agarose column followed by quantification of RyR content
in each fraction using a RyR-specific ELISA assay as described
previously [22].
Synthesis and Purification of FRET Acceptors
Cy3NTA and Cy5NTA were synthesized and then purified via
thin layer chromatography as described previously [22]. Yields
quantified spectrophotometrically (Cy3e550=150,000 M
21 cm
21;
Cy5 e650=250,000 M
21 cm
21) were typically 40% of starting
material. Before use, a dried 10 nanomole aliquot of either
compound was charged with 20 nanomoles of NiCl2 in water.
FRET Imaging
Three days after transfection, HEK-293T cells expressing each
His-tagged GFP-RyR1 fusion protein were imaged at 406
magnification using a Leica TCS SP5 confocal microscope
(Mannheim, Germany) as described previously [22]. Briefly, cells
were incubated with 200 ng/ml streptolysin O (to permeabilize
the cells) and 1 mM Cy3NTA for 10 min in buffer consisting of
125 mM NaCl, 5 mM KCl, 6 mM glucose, and 25 mM HEPES
pH 7.6. Initial GFP and Cy3 fluorescence levels of the cells were
determined from image Z-stacks recorded from the cells. Cy3NTA
was then selectively bleached by illuminating the cells with 515–
560 nm light from a mercury lamp attached to the confocal
microscope for 5 min (Fig. S4). GFP and Cy3 fluorescence of the
cells was then re-measured and the FRET efficiency (E) calculated
from the resulting increase in GFP fluorescence after photo-
bleaching of Cy3NTA using:
E~((Fpostbleach{Fprebleach)=Fpostbleach)
where Fprebleach and Fpostbleach are GFP fluorescence intensities
before and after photobleaching of Cy3NTA, respectively.
Fpostbleach values were corrected for direct photobleaching of
GFP, which was determined from control experiments to be
10.2%. In some cases, FRET efficiency values were converted to
intermolecular distances as described below.
In vitro FRET measurements- The ability of either Cy3NTA or
Cy5NTA to undergo energy transfer with GFP containing an N-
terminal His10 tag (GFPHis10) was determined as described
previously [22]. The Fo ¨rster distances (at which 50% energy
transfer occurred) for either the GFP/Cy3NTA or GFP/
Cy5NTA FRET pair were calculated from the GFP emission
spectrum and the absorbance spectrum of Cy3/5NTA as
described previously [22].
The distance from the GFP chromophore to the bound FRET
acceptor was calculated using:
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1=6
where R represents the donor/acceptor distance, R0 represents the
Fo ¨rster distance for the donor/acceptor pair, n represents the
number of Cy3/5NTA molecules bound per His10 tag and E
represents the measured energy transfer efficiency.
Distance Measurements Relative to the RyR1 Crystal
Structure
Reference distance measurements were made between the
peptide bond carbonyl carbons of selected amino acid residues
within the published crystal structure of an N-terminal 559
amino acid fragment of RyR1 (PDB ID 2XOA) [11] using the
UCSF Chimera package from the Resource for Biocomputing,
Visualization, and Informatics at the University of California,
San Francisco (supported by NIH P41 RR001081) [31].
Measurements from the N-terminus of RyR1 were taken from
the N-terminal nitrogen atom of residue 12, the first residue in
the crystal structure.
Triangulations of GFP Insertions
Using Chimera, spheres were centered upon the carbonyl
carbon atoms of the various amino acid positions where His10-tags
were inserted. The radii of these spheres were equivalent to the
donor/acceptor distances determined from the FRET measure-
ments. The chromophoric center of the crystal structure of GFP
(PDB ID 1GFL) [26] was then placed at the intersection point of
these spheres. The resulting location of all 3 GFP insertions
relative to the atomic structure of the N-terminal RyR1 domain
[11] was depicted using Chimera.
Docking to the Cryo EM Structure of RyR1 and
Refinement of the GFP Positions
The ‘‘Fit in Map’’ function in Chimera was used to dock the
atomic structure of the N-terminal RyR1 domain [11] to a 10 A ˚
resolution 3D structure of the open state of RyR1 (EMBD ID
1607) [15] at the cytoplasmic vestibule location indicated in the
crystallographic report [11]. The triangulated GFPs were then
initially placed in positions relative to the N-terminal domain
crystal structure determined as described above. The distance
from each GFP position to His10 positions in each of the 4 subunits
was determined as described above (see in vitro FRET measure-
ments) assuming 1:1 Cy3NTA:His10 tag binding stoichiometry.
The theoretical energy transfer rate, kT(r) for each of these 4
distances was determined using:
kT(r)~tD
{1(R0=R)
6
where tD = fluorescence lifetime of the donor (GFP) in the
absence of acceptor, R0=F o ¨rster distance for the GFP/Cy3NTA
pair (62.5 A ˚) and R=distance between the given donor/acceptor
pair. The individual energy transfer rates for FRET from GFP to
Cy3NTA targeted to each of the 4 subunits were then summed to
yield kT(r)sum and the theoretical energy transfer efficiency for
FRET between all 4 subunits was determined using:
E~kT(r)sum=(tD
{1zkT(r)sum)
The position of the each triangulated GFP was then adjusted
iteratively until this theoretical FRET value was within 20% of the
measured FRET value (if possible). This process was repeated for
all donor/acceptor positions and the results summarized in
Table 2.
Supporting Information
Figure S1 Western blot analysis of His-tagged GFP-
RyR1 fusion proteins. Cell lysates expressing RyR fusion
constructs with GFP at position 1 (A), 291 (B) or 620 (C) were
analyzed for RyR content using Western blot analysis as described
in Methods. Numbers in each panel refer to positions of molecular
weight standards (in kDa). wtRyR1 and HEK-293T refers to
wildtype RyR1 and untransfected cells used as positive and
negative controls, respectively. Each Western blot was repeated at
least 3 times with similar results.
(TIF)
Figure S2 Determination of surface exposure of His10
tags inserted into GFP-RyR1 fusion proteins. NTA-
agarose fractionation of crude lysates from HEK-293T cells
expressing indicated GFP-RyR1 fusion proteins. Columns were
washed as indicated (dotted lines). FT=flow through. Im=imi-
dazole. Data points indicate relative levels of RyR immunoreac-
tivity in consecutive 120 ml fractions quantified by an RyR-specific
ELISA assay (see Methods). Scale bar, 0.25 arbitrary units.
(TIF)
Figure S3 Functional comparison of the Cy3NTA and
Cy5NTA FRET acceptors. (A) In vitro time-based fluorescence
measurements of GFPHis10 incubated with indicated concentra-
tions (in mM) of Cy3NTA (red trace) or Cy5NTA (blue). EDTA
(which disrupts binding of these reagents to the His tag via
chelation of the Ni
2+ atom) was added as indicated (arrows). (B)
Concentration dependence of FRET from GFPHis10 to either
Cy3NTA (red curve) or Cy5NTA (blue) determined using in vitro
measurements.
(TIF)
Figure S4 Optimization of experimental conditions for
cell-based FRET measurements of His-tagged GFP RyR1
fusion constructs. (A) Timecourse of recovery of donor
fluorescence from GFP
1His
N-term construct expressed in HEK-
293T cells after photobleaching Cy3NTA for the times indicated.
FRET efficiency was quantified as described in Methods. (B)
Cy3NTA concentration dependence for determining FRET
efficiency via acceptor photobleaching. Data points each represent
mean +/2 SEM for 14 cells (A) and 8–21 cells (B).
(TIF)
Table S1 Effect of Different Cy3/5NTA Binding Stoi-
chiometries on Calculated Donor/Acceptor Distances.
aCalculated donor/acceptor distance for GFPHis10 construct using
either Cy3NTA or Cy5NTA as FRET acceptor.
bDifference in
calculated donor/acceptor distances using the two FRET
acceptors.
(DOCX)
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